Status:
COMPLETED
The Effect of Eye Mask Applied on Patients Undergoing Coronary Artery Bypass Graft Surgery
Lead Sponsor:
Kutahya Health Sciences University
Conditions:
Coronary Artery Disease
Sleep Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Introduction: Coronary Artery Bypass Graft (CABG) performed with open heart surgery technique is a successful operation in the treatment of cardiovascular diseases. Incision of the sternum region, sap...
Detailed Description
Cardiovascular diseases (CVDs) are among the leading causes of death globally. Coronary Erter Bypass Graft (CABG) performed with open heart surgery technique is a successful operation in the treatment...
Eligibility Criteria
Inclusion
- Over 18 years old
- Those under 65 (Studies show that nighttime awakenings and sleep durations change with age (Lie et al., 2018)
- Can speak Turkish
- Those who agreed to participate in the study
- Those who have not had open heart surgery before
- No emergency bypass surgery
- No intra-aortic balloon pump or pacemaker
- Not taking inotropic drugs
- Those who have not consumed coffee or hypnotic drugs at least 12 hours before
- Those who have not been working the night shift for the last 3 months
- No history of chronic pain (eg arthritis)
- Able to wear an eye mask on their own
- Not addicted to alcohol and drugs
- Does not have a psychological problem (such as depression, anxiety disorder)
- No anxiolytic use
- No chronic sleep problems
- Not using sleeping pills
Exclusion
- Low risk factor for complications (eg ejection fraction \< 35%).
- During CABG surgery, mitral valve repair or replacement (Each type of heart surgery will differ in terms of operation time, site of surgery, recovery time, and length of hospital stay, which may affect the patient's anxiety.)
- Patients with chest tube and drain
- Patients with vision problems
- Patients with hearing problems
- Patients with claustrophobia
Key Trial Info
Start Date :
July 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06010498
Start Date
July 10 2023
End Date
March 1 2024
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Necibe
Kütahya, Turkey (Türkiye), 43000